Regulation of the hepatic endothelin system in advanced biliary fibrosis in rats

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 6, 2000, Pages 507-512

  Rothermund, L ^a   Leggewie, S ^a   Schwarz, A ^a   Thone Reinecke, C ^a   Cho, J J ^a   Bauer, C ^a   Paul, M ^a   Neumayer, H H ^a   Schuppan, D ^a   Hocher, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bile duct obstruction; Endothelin (ET); ET(A) and ET(B) receptor; ET receptor antagonism; Liver cirrhosis; Silymarin

Indexed keywords

ANTIFIBROTIC AGENT; DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; RECEPTOR SUBTYPE; SILYMARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT OBSTRUCTION; CELL MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HEPATOBILIARY SYSTEM; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR DENSITY; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SCATCHARD PLOT;

EID: 0033892872     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.074     Document Type: Article

References (27)

1. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells
2. Sinusoidal endothelial liver cells in vitro release endothelin - augmentation by transforming growth factor beta and Kupffer cell- conditioned media
3. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction
4. Hepatic effects of endothelin: Metabolism of [125I]endothelin-1 by liver-derived cells
5. Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes
6. Endothelin, a potent peptide agonist in the liver
7. Endothelins 1 and 3: Potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine
8. Endothelin-1 induces direct constriction of hepatic sinusoids
9. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats
10. Role of the paracrine liver endothelin system in the pathogenesis of CCI4-induced liver injury
11. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats
12. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing
13. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats
14. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues
15. Endothelin system - Dependent cardiac remodeling in renovascular hypertension
16. Renal endothelin system in polycystic kidney disease
17. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
18. Comparison of the regulation of endothelin-2 and endothelin-converting enzyme-1-beta by forskolin and TNF-alpha in ACHN cells
19. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: Role of ETA receptors for endothelin regulation
20. Endothelin-1 inhibits endothelin-converting enzyme-1 expression in cultured rat pulmonary endothelial cells
21. Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: Relationship with hepatic hemodynamics
22. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
23. Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1
24. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats
25. The paradox of beta-adrenergic blockade for the management of congestive heart failure